Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Wessam H. Abd-Elsalam, Yosra Ibrahim Nagy & Samar M. Abouelatta. (2021) Tailoring thixotropic mixed-lipid nanoconstructs of voriconazole for the management of Vulvovaginal candidiasis: Formulation, statistical optimization, in vitro characterization and in vivo assessment. Drug Delivery 28:1, pages 1877-1889.
Read now
Read now
Sara Blanco-Dorado, Cristina Cea-Arestin, Alba González Carballo, Ana Latorre-Pellicer, Olalla Maroñas Amigo, Gema Barbeito Castiñeiras, María Luisa Pérez del Molino Bernal, Manuel Campos-Toimil, Anxo Fernández-Ferreiro & María J. Lamas. (2019) An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting. Journal of Chemotherapy 31:1, pages 49-57.
Read now
Read now
Monica A Donnelley, Elizabeth S Zhu & George R Thompson$suffix/text()$suffix/text(). (2016) Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections. Infection and Drug Resistance 9, pages 79-86.
Read now
Read now
Pierre-Régis Burgel, André Paugam, Dominique Hubert & Clémence Martin. (2016) Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy. Infection and Drug Resistance 9, pages 229-238.
Read now
Read now
David Allen, Dustin Wilson, Richard Drew & John Perfect. (2015) Azole antifungals: 35 years of invasive fungal infection management. Expert Review of Anti-infective Therapy 13:6, pages 787-798.
Read now
Read now
Matthew L Eldridge, Cindy J Chambers, Victoria R Sharon & George R Thompson$suffix/text()$suffix/text(). (2014) Fungal infections of the skin and nail: new treatment options. Expert Review of Anti-infective Therapy 12:11, pages 1389-1405.
Read now
Read now
Melanie W. Pound, Mary L. Townsend, Vincent Dimondi, Dustin Wilson & Richard H. Drew. (2011) Overview of treatment options for invasive fungal infections. Medical Mycology 49:6, pages 561-580.
Read now
Read now
Articles from other publishers (30)
Guolin Li, Qinhui Li, Changji Zhang, Qin Yu, Qi Li, Xiaoshi Zhou, Rou Yang, Xuerong Yang, Hailin Liu & Yong Yang. (2023) The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals. Frontiers in Genetics 14.
Crossref
Crossref
Anália Carmo, Marilia Rocha, Patricia Pereirinha, Rui Tomé & Eulália Costa. (2023) Antifungals: From Pharmacokinetics to Clinical Practice. Antibiotics 12:5, pages 884.
Crossref
Crossref
Abid A. Haseeb, Abdelrahman M. Elhusseiny, Mohammad Z. Siddiqui, Kinza T. Ahmad & Ahmed B. Sallam. (2021) Fungal Endophthalmitis: A Comprehensive Review. Journal of Fungi 7:11, pages 996.
Crossref
Crossref
Saraswathi Nagaraj, Sivakami Manivannan & Shoba Narayan. (2021) Potent antifungal agents and use of nanocarriers to improve delivery to the infected site: A systematic review. Journal of Basic Microbiology 61:10, pages 849-873.
Crossref
Crossref
Paladugu Venkata NaveenSeru Ganapaty. (2021) A new Validated Stability Indicating RP-UFLC Method for the Estimation of Voriconazole in presence of internal standard. Research Journal of Pharmacy and Technology, pages 4825-4831.
Crossref
Crossref
Kazuhiro Ito, Yasuo Kizawa, Genki Kimura, Yuki Nishimoto, Leah Daly, Ian Knowles, Mark Hows, John Ayrton & Pete Strong. (2021) Relationship between anti-fungal effects and lung exposure of PC945, a novel inhaled antifungal agent, in Aspergillus fumigatus infected mice. European Journal of Pharmaceutical Sciences 163, pages 105878.
Crossref
Crossref
Jose Cadena, George R. ThompsonIIIIII & Thomas F. Patterson. (2021) Aspergillosis. Infectious Disease Clinics of North America 35:2, pages 415-434.
Crossref
Crossref
Su-jie Jia, Ke-qin Gao, Pan-hao Huang, Ren Guo, Xiao-cong Zuo, Qing Xia, Shuang-yao Hu, Zhen Yu & Yue-liang Xie. (2021) Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole. Frontiers in Pharmacology 12.
Crossref
Crossref
Lindsey Cass, Alison Murray, Amanda Davis, Kathy Woodward, Muna Albayaty, Kazuhiro Ito, Pete Strong, John Ayrton, Charlie Brindley, Jayne Prosser, John Murray, Eddie French, Phillip Haywood, Christopher Wallis & Garth Rapeport. (2020) Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent. Pharmacology Research & Perspectives 9:1.
Crossref
Crossref
Emil Szepiński, Dorota Martynow, Piotr Szweda, Maria J. Milewska & Sławomir Milewski. (2019) Voriconazole-Based Salts Are Active against Multidrug-Resistant Human Pathogenic Yeasts. Molecules 24:20, pages 3635.
Crossref
Crossref
George R. ThompsonIIIIII, Charles R. Krois, Verena K. Affolter, Angela D. Everett, E. Katarina Varjonen, Victoria R. Sharon, Anil Singapuri, Michael Dennis, Ian McHardy, Hong Sik Yoo, Dawn M. Fedor, Nathan P. Wiederhold, Phylicia A. Aaron, Angie Gelli, Joseph L. Napoli & Stephen D. White. (2019) Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort. Antimicrobial Agents and Chemotherapy 63:2.
Crossref
Crossref
Thomas Colley, Gurpreet Sehra, Anuradha Chowdhary, Alexandre Alanio, Steven L. Kelly, Yasuo Kizawa, Darius Armstrong-James, Matthew C. Fisher, Andrew G. S. Warrilow, Josie E. Parker, Diane E. Kelly, Genki Kimura, Yuki Nishimoto, Mihiro Sunose, Stuart Onions, Damien Crepin, Franz Lagasse, Matthew Crittall, Jonathan Shannon, Matthew McConville, John King-Underwood, Alan Naylor, Stéphane Bretagne, John Murray, Kazuhiro Ito, Pete Strong & Garth Rapeport. (2018)
In Vitro
and
In Vivo
Efficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, on Aspergillus fumigatus Infection
. Antimicrobial Agents and Chemotherapy 62:5.
Crossref
Crossref
Genki Kimura, Takahiro Nakaoki, Thomas Colley, Garth Rapeport, Pete Strong, Kazuhiro Ito & Yasuo Kizawa. (2017)
In Vivo
Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice
. Antimicrobial Agents and Chemotherapy 61:9.
Crossref
Crossref
Linda Christian Carrijo-Carvalho, Viviane Peracini Sant'ana, Annette Silva Foronda, Denise de Freitas & Fabio Ramos de Souza Carvalho. (2017) Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus. Survey of Ophthalmology 62:2, pages 203-218.
Crossref
Crossref
Ikuko Nakamura, Ryuichi Kanasaki, Koji Yoshikawa, Shigetada Furukawa, Akihiko Fujie, Hiroshi Hamamoto & Kazuhisa Sekimizu. (2016) Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection. The Journal of Antibiotics 70:1, pages 41-44.
Crossref
Crossref
Jose Cadena, George R. ThompsonIIIIII & Thomas F. Patterson. (2016) Invasive Aspergillosis. Infectious Disease Clinics of North America 30:1, pages 125-142.
Crossref
Crossref
Nicolette R. Holt & Karin A. Thursky. 2016. Drug Dosing in Obesity. Drug Dosing in Obesity
77
96
.
George Korres, Joseph Meletiadis, Alexander Delides, Anastasia Antoniadou, George Petrikkos, Loukia Zerva, Ioannis Yiotakis, Maria Siopi, Eleni Kalogeropoulou, Ilias Georgantis & Thomas P. Nikolopoulos. (2015) Fungal malignant otitis externa caused by Alternaria chlamydospora: first case report. JMM Case Reports 2:1.
Crossref
Crossref
Taotao Wang, Huifang Zhu, Jinyao Sun, Xiaoliang Cheng, Jiao Xie, Haiyan Dong, Limei Chen, Xue Wang, Jianfeng Xing & Yalin Dong. (2014) Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections. International Journal of Antimicrobial Agents 44:5, pages 436-442.
Crossref
Crossref
Jenny Walton & Chris Coulson. (2014) Fungal Malignant Otitis Externa with Facial Nerve Palsy: Tissue Biopsy Aids Diagnosis. Case Reports in Otolaryngology 2014, pages 1-5.
Crossref
Crossref
Dmitriy M. Volochnyuk, Oleksandr O. Grygorenko & Alina O. Gorlova. 2014. Fluorine in Heterocyclic Chemistry Volume 2. Fluorine in Heterocyclic Chemistry Volume 2
577
672
.
Johan G. C. van Hasselt, Natasha K. A. van Eijkelenburg, Alwin D. R. Huitema, Jan H. M. Schellens & Antoinette Y. N. Schouten-van Meeteren. (2013) Severe Skin Toxicity in Pediatric Oncology Patients Treated with Voriconazole and Concomitant Methotrexate. Antimicrobial Agents and Chemotherapy 57:6, pages 2878-2881.
Crossref
Crossref
Isabel Spriet, Roger J. M. Brüggemann, Pieter Annaert, Philippe Meersseman, Eric Van Wijngaerden, Katrien Lagrou & Ludo Willems. (2013) Pharmacokinetic Profile of Voriconazole in a Critically Ill Patient on Therapeutic Plasma Exchange. Therapeutic Drug Monitoring 35:1, pages 141-143.
Crossref
Crossref
Thomas Cherian, Alexandros Giakoustidis, Satoshi Yokoyama, Michael Heneghan, John O’Grady, Mohamed Rela, Julia Wendon, D. Nigel Heaton & Anita Verma. (2012) Treatment of Refractory Cerebral Aspergillosis in a Liver Transplant Recipient With Voriconazole: Case Report and Review of the Literature. Experimental and Clinical Transplantation 10:5, pages 482-486.
Crossref
Crossref
Charalampos Dokos, Stephanie Pieper, Thomas Lehrnbecher & Andreas H. Groll. (2012) Pharmacokinetics, Safety and Efficacy of Voriconazole in Pediatric Patients: An Update. Current Fungal Infection Reports 6:2, pages 121-126.
Crossref
Crossref
Malcolm D. Richardson & David W. Warnock. 2012. Fungal Infection. Fungal Infection
32
90
.
Anna Janik-Moszant, Aleksander Matyl, Iwona Rurańska, Agnieszka Machowska- Majchrzak, Ewa Kluczewska & Tomasz Szczepański. (2012) Invasive fungal infection of the central nervous system in a patient with acute myeloid leukaemia.. Polish Journal of Radiology 77:1, pages 54-57.
Crossref
Crossref
Si-Hyun Kim, Dong-Seok Yim, Su-Mi Choi, Jae-Cheol Kwon, Seunghoon Han, Dong-Gun Lee, Chulmin Park, Eun-Young Kwon, Sun Hee Park, Jung-Hyun Choi & Jin-Hong Yoo. (2011) Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. International Journal of Infectious Diseases 15:11, pages e753-e758.
Crossref
Crossref
Hagen Ott & Peter H. Hoeger. 2011. Harper's Textbook of Pediatric Dermatology. Harper's Textbook of Pediatric Dermatology.
Sanjay G. Revankar & Deanna A. Sutton. (2010) Melanized Fungi in Human Disease. Clinical Microbiology Reviews 23:4, pages 884-928.
Crossref
Crossref